Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
151 USD | -0.20% | -0.30% | -3.71% |
11:46am | J&J: positive trial for Tremfya in ulcerative colitis | CF |
11:41am | Valneva Names New Chief Scientific Officer | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.71% | 364B | |
+37.83% | 705B | |
+32.82% | 583B | |
+20.23% | 332B | |
+4.91% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.84% | 169B | |
-1.18% | 162B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Transcript : Johnson & Johnson Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 09